Nuclear Cardiology in India is underutilized. Contributing factors include high cost of starting Nuclear medicine facility, stringent regulations, small pool of trained nuclear physicians and technologists, high cost of radio pharmaceuticals and supply issues, poor penetrance of nuclear medicine in rural areas, inadequate exposure of cardiologists during training to the advantages of nuclear cardiology. India is poised to see an epidemic of coronary artery disease (CAD) and diabetes by end of few decades and nuclear cardiology would make significant contributions to handle this epidemic. Government and insurance companies advocacy is necessary for nuclear Cardiology to get its important rightful place in the management of CAD in India.
C oronary artery disease (CAD) in India is assuming epidemic proportions (1) . It was reported by the Registrar General of India that CAD led to 23% of total and 32% of adult deaths in 2010-2013. The prevalence of CAD in India has increased over the last 60 years from 1% to 10% in urban populations and <1% to 6% in rural populations. Important risk factors for CAD in India according to case control studies are dyslipidemias, smoking, hypertension, diabetes, abdominal obesity, psychosocial stress, unhealthy diet and physical inactivity. Patients from India with established CAD are younger than their western counterparts (2) .
Nuclear myocardial perfusion imaging (MPI) is a wellestablished technique for diagnosis of myocardial ischemia, quantifying extent of ischemia and giving prognostic information to decide management strategies. Robust literature over several years has established its utility (3) .
It would be expected that a modality with such an established powerful performance would be widely used in parts of the world where the CAD incidence is on the rise and where access to angiography is limited.
In this article, we will discuss 1) whether there is a role for MPI in the CAD demographics and health economics in India 2) what drives the current utilization of MPI in the country 3) opportunities and challenges in using MPI in India.
Is there a role for MPI in the CAD demographics in the health economics of the region?
A WHO report indicated that by the end of this century, India will have over half of the CAD patients in the world (4).
India will have more than 10% of the world's diabetics in the next decade and high prevalence of other traditional risk factors (5, 6) . There is thus an obvious need for a robust infrastructure to detect and treat CAD and to enhance preventive efforts. There is a striking dichotomy between health care facilities in urban and rural areas. In many urban areas, the most advanced diagnostic and therapeutic facilities including CT, MRI, Nuclear Medicine (NM), Coronary angiography along with facilities for coronary revascularization are available and are at par with the best in the world.
Such facilities are woefully inadequate in the rural areas.
There is also a general reluctance to avoid invasive procedures. Thus, MPI with its ability to detect CAD Annals of Nuclear Cardiology Vol. 
What drives the current utilization of MPI in India?
The ground reality, however, is that MPI is grossly 
Opportunities and challenges in using MPI in India
In the smaller cities and rural areas hospitals generally lack sophisticated equipment and highly trained personnel. Patients are likely to have more access to stress echocardiography, and sometimes even coronary angiography, than MPI. These tests are also likely to be cheaper than MPI. Although a minority of government-run hospitals may provide MPI at a subsidized cost, the average cost to patients of MPI with a Tc-99m-based agent is approximately $180 (compared to the average monthly middle-class income of about $500) (9) . In addition, the uninterrupted availability of tracer in areas remote from big cities is also likely to be a problem. Thus, promoting NC in smaller cities and rural areas is likely to be more challenging, and will require investment in equipment and training of personnel and the continuous supply of radionuclide tracers at an affordable cost.
Conclusion
For nuclear cardiology to thrive in India (10), a multifactorial approach of introducing exposure during training of cardiologists to nuclear cardiology, having more centers offering nuclear procedures, with a larger pool of trained nuclear physicians and technologists, and government advocacy and insurance company intervention insisting on incorporation of nuclear scans in diagnostic and management algorithms for CAD management will be required.
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